Clinical trial
A Long-Term International, Extension of Study GNC-003 With GNbAC1 in Patients With Relapsing Remitting Multiple Sclerosis
NCT03239860 is registered in ClinicalTrials.gov with GeNeuro SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term International, Extension of Study GNC-003 With GNbAC1 in Patients With Relapsing Remitting Multiple Sclerosis
- Lead sponsor
- GeNeuro SA
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 6, 2017
- Completion date
- November 14, 2018
- Enrollment
- 220 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.